Key takeaway
Pooling 25 randomized trials with 1,302 older adults with sarcopenia, resistance training improved muscle strength (ES = 0.71), grip strength (0.55), walking ability (0.41) and lean mass (0.22), all p < 0.05. The largest effect, muscle quality (1.25), came from only two studies, and the cumulative-duration targets are exploratory.
Study design
Evidence review
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Sarcopenia is age-related loss of muscle mass and function, and resistance training is the main treatment, but how much and how hard to train is unclear. The authors pooled trials to measure the effect on body composition and physical performance, and to look at age, intensity and dose-response patterns within the FITT-VP framework (frequency, intensity, time, type, volume, progression).
Who and how
Systematic review and meta-analysis of randomized controlled trials of resistance training (RT) in older adults with sarcopenia, from a search of multiple databases. Body composition, muscle strength (MS) and functional performance data were extracted. Moderator analyses examined participant and intervention characteristics, and meta-regression explored dose-response. The abstract does not name the databases or the search dates.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 125 RCTs with 1,302 participants were included. Resistance training improved muscle strength (ES = 0.71), lean mass (ES = 0.22), walking ability (ES = 0.41), grip strength (ES = 0.55) and muscle quality (ES = 1.25), and reduced fat mass (ES = -0.17), all with p < 0.05.
- 2The muscle quality effect size was large but was based on only two studies and needs cautious interpretation.
- 3Meta-regression showed a significant non-linear relationship between total training duration and functional gains, with estimated optimal cumulative durations of about 1,043 min for muscle strength and about 2,716 min for walking ability.
- 4The authors call these durations exploratory indicators and suggest intensity of 60-80% of one-repetition maximum (1RM) within individualized programming.
Limits & uncertainty
- 1The most striking effect (muscle quality, ES = 1.25) rests on only two studies, so it is unreliable.
- 2The dose-response durations come from pooled meta-regression across different trials, so they are exploratory and cannot be treated as prescriptions; the abstract does not report heterogeneity or risk of bias.
- 3The abstract gives no confidence intervals for the effect sizes, so precision is unclear.
- 4This reading is based on the abstract only.
What to take from it
For older adults with sarcopenia, supervised resistance training is supported as a way to improve strength and walking. The minutes and 60-80% 1RM figures are rough pooled guides, not a plan for any one person; a clinician or physiotherapist should set the program.
Reading your own data
Log sessions, weights, repetitions and total training minutes, plus grip strength and a repeatable walking test such as time over a set distance. Compare yourself against your own past results using the same method over months.
How to read this evidence
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Objective
This systematic review and meta-analysis aimed to address key gaps in understanding the role of resistance training (RT) as an intervention to mitigate age-related sarcopenia. Specifically, it examined: (i) effects on body composition and physical performance; (ii) moderating influences of age and training intensity; and (iii) the presence of a dose-response relationship within the FITT-VP framework.
Methods
A comprehensive search of multiple databases identified randomized controlled trials (RCTs) evaluating RT in older adults with sarcopenia. Data on body composition, muscle strength (MS), and functional performance were extracted. Moderator analyses assessed the impact of participant and intervention characteristics, and meta-regression was performed to explore dose-response patterns.
Results
Twenty-five RCTs involving 1,302 participants were included. RT produced significant improvements in MS (ES = 0.71), lean mass (LM, [ES = 0.22]), fat mass (FM, [ES = - 0.17]), walking ability (WA, [ES = 0.41]), grip strength ([GS, [ES = 0.55]), muscle quality (MQ, [ES = 1.25]) (all p < 0.05), but this large effect size was based on only two studies and requires caution interpretation. Dose-response meta-regression revealed a significant non-linear relationship between total RT duration and functional gains, with optimal estimated cumulative volumes of ~ 2,716 min for WA.
Conclusion
RT is a robust, evidence-based strategy for enhancing MS, functional performance, and body composition in sarcopenic older adults. Findings suggest approximate cumulative duration ranges (~ 1,043 min for MS and ~ 2,716 min for WA) that were associated with maximal gains in pooled analyses. These values should be interpreted as exploratory indicators supporting individualized programming within the FITT-VP framework. Clinicians and exercise practitioners should tailor intensity (60-80% 1RM), frequency, and progression to optimize adherence, effectiveness, and long-term functional outcomes in sarcopenia management.
Sources & attribution
Optimizing prescription of resistance training for body composition, muscle strength, and physical performance in older adults with sarcopenia: a systematic review and meta-analysis.
Tan Z, Jiang Y, Candow DG, Castagna C, Wang X, Zheng H.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026-01-21
DOI: 10.1186/s11556-025-00399-2 ↗PubMed · 41566419 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

